Pieris Pharmaceuticals Inc (PIRS) stock has risen 97.52% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives PIRS stock a score of 76 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 98. PIRS's rank also includes a fundamental score of 69. In addition to the average rating from Wall Street analysts, PIRS stock has a mean target price of $8.50. This means analysts expect the stock to climb 52.60% over the next 12 months. The short-term technical score for PIRS is 61.
PIRS has an Overall Score of 76. Find out what this means to you and get the rest of the rankings on PIRS!
Pieris Pharmaceuticals Inc (PIRS) stock has risen 6.41% while the S&P 500 has risen 0.18% as of 9:41 AM on Thursday, Sep 9. PIRS has risen $0.34 from the previous closing price of $5.23 on volume of 6,416 shares. Over the past year the S&P 500 is higher by 33.05% while PIRS has risen 97.52%. PIRS lost -$0.84 per share in the over the last 12 months.
Click Here to get the full Stock Report for Pieris Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
